If you're holding shares of Vertex Pharmaceuticals or thinking about adding some to your portfolio, you're not alone in ...

Vertex Pharmaceuticals (VRTX) has recently been on Zacks.com's list of the most searched stocks. Therefore, you might want to ...

Vertex Pharmaceuticals has been a clear winner in the pharmaceutical sector. Over the past two decades, this powerhouse has ...

Vertex (VERX) just introduced Kintsugi powered by Vertex, an AI-based tax automation platform aimed at helping small and mid-sized businesses streamline compliance. This move highlights the company’s ...

Vertex broke those barriers with Journavx, the first non-opioid prescription pain killer in more than two decades, earning ...

ClearBridge Investments, an investment management company, released its “ClearBridge Large Cap Growth Strategy” third-quarter 2025 investor letter. A copy of the letter can be downloaded here.

Vertex Pharmaceuticals’ CRISPR-based therapy made history as the first drug of its type, transforming care options for sickle ...

Vertex Pharmaceuticals Incorporated remains a buy despite recent share price weakness, supported by its dominant cystic fibrosis franchise and robust late-stage pipeline. Alyftrek's launch extends ...

Vertex Pharmaceuticals (VRTX) shares saw mild movement today, with the stock ticking slightly higher over the past week.

Vertex Inc. (NASDAQ: VERX) announced the launch of Kintsugi powered by Vertex, a new AI-native tax automation solution ...